| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Management > Top Consultant Says Shyness & Telemarketing Attrition Are Linked |
|
Useful Advices - Top Consultant Says Shyness & Telemarketing Attrition Are Linked
Jack & Jill went up a hill to fetch a pail of water. Have you ever wondered why Jack fell down and broke his crown? His According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product pail was full of holes, so most of the water he fetched was gone by the time he reached his destination. Despairing over ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in his, he resolved to retrieve more water but the only way to do so, he thought, was to rush back and forth, and that contin lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ous cycle of desperation caused his mishap. Telemarketing companies, and companies that telemarket are modern-day Jacks. here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe They’re trying to find and retain quality people to staff their phones, but their pails have holes in them, as well. Inste d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro d of repairing their pails, they rush about, wasting energy and resources in an exorbitantly costly battle. They need to ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ake a long, hard look at the holes in their recruiting systems, if they wish to keep more of their people and reduce attri easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ion. One of these holes is defining who WILL DEFINITELY NOT ACHIEVE AS TELEMARKETERS. Let’s assume that today’s typical nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically elemarketing unit loses, at minimum, twenty percent of its staff each month. How much of that turnover is attributable to and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ eople that should never have been hired? I’d say 80-90%. These are folks who should have been screened out before being p ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi t on the phones. Some of them are shy. According to Stanford research, 80% of Americans are shy to one extent or another ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a and in one venue or another. A big and burly outside salesman may be exuberant face-to-face, but a meek and retiring ty dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod e on the phone. One of my trainees that fit this description said: “I’m great face to face, but I hate the phone because cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin can’t see how someone is reacting to me!” That is a signature characteristic of a phone-shy person. He or she is so preo tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen cupied with how they’re doing, second to second, and whether they’re going to be rejected, or negatively judged, that they t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel monitor their performances instead of being in real-time and in synch with buyers. When distracted by inner signals and t ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust oughts the shy person’s listening becomes distorted, and they’re slow to react to customer feedback, which they distort, e y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products roneously believing it is filled with rejection. Customers don’t have to beat them up; shy people do it to themselves. T . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ere are ways to screen applicants for phone shyness and for other problems that will limit their success or simply doom th elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip m to failure. Identifying and then not hiring these folks is one of the kindest and most cost effective things you can do tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Entrepreneur Life Journey - Enlighten Millionaires 7 Things That Distinguish a Good Sales Letter From the Rest
|